Liu J - Search Results

1

Effectiveness of High-risk Human Papillomavirus Testing for Cervical Cancer Screening in China: A Multicenter, Open-label, Randomized Clinical Trial.

Zhang J, Zhao Y, Dai Y, Dang L, Ma L, Yang C, Li Y, Kong L, Wei L, Zhang S, Liu J, Xi M, Chen L, Duan X, Xiao Q, Abulizi G, Zhang G, Hong Y, Gao X, Zhou Q, Xie X, Li L, Niyazi M, Zhang Z, Tuo J, Ding Y, Si M, Chen F, Song L, Qiao Y, Lang J. Zhang J, et al. Among authors: liu j. JAMA Oncol. 2021 Feb 1;7(2):263-270. doi: 10.1001/jamaoncol.2020.6575. JAMA Oncol. 2021. PMID: 33377903 Free PMC article. Clinical Trial.

2

[Progress in researches on A-kinase anchor proteins in sperm].

Li Y, Liu J. Li Y, et al. Among authors: liu j. Zhonghua Nan Ke Xue. 2004 Sep;10(9):692-4. Zhonghua Nan Ke Xue. 2004. PMID: 15497715 Review. Chinese.

3

Low initial human papillomavirus viral load may indicate worse prognosis in patients with cervical carcinoma treated with surgery.

Deng T, Feng Y, Zheng J, Huang Q, Liu J. Deng T, et al. Among authors: liu j. J Gynecol Oncol. 2015 Apr;26(2):111-7. doi: 10.3802/jgo.2015.26.2.111. J Gynecol Oncol. 2015. PMID: 25872892 Free PMC article.

4

Efficacy of quadrivalent human papillomavirus vaccine against persistent infection and genital disease in Chinese women: A randomized, placebo-controlled trial with 78-month follow-up.

Wei L, Xie X, Liu J, Zhao Y, Chen W, Zhao C, Wang S, Liao X, Shou Q, Qiu Y, Qiao Y, Saah AJ. Wei L, et al. Among authors: liu j. Vaccine. 2019 Jun 12;37(27):3617-3624. doi: 10.1016/j.vaccine.2018.08.009. Epub 2018 Aug 16. Vaccine. 2019. PMID: 30122646 Clinical Trial.

5

Safety of a quadrivalent human papillomavirus vaccine in a Phase 3, randomized, double-blind, placebo-controlled clinical trial among Chinese women during 90 months of follow-up.

Chen W, Zhao Y, Xie X, Liu J, Li J, Zhao C, Wang S, Liao X, Shou Q, Zheng M, Saah AJ, Wei L, Qiao Y. Chen W, et al. Among authors: liu j. Vaccine. 2019 Feb 4;37(6):889-897. doi: 10.1016/j.vaccine.2018.12.030. Epub 2019 Jan 9. Vaccine. 2019. PMID: 30638797 Clinical Trial.

6

Sentinel lymph node biopsy versus pelvic lymphadenectomy in early-stage cervical cancer: a multi-center randomized trial (PHENIX/CSEM 010).

Tu H, Huang H, Xian B, Li J, Wang P, Zhao W, Chen X, Xie X, Wang C, Kong B, Xiao J, Zhang P, Liu J; PHENIX Investigators and the CSEM group. Tu H, et al. Among authors: liu j. Int J Gynecol Cancer. 2020 Nov;30(11):1829-1833. doi: 10.1136/ijgc-2020-001857. Epub 2020 Sep 24. Int J Gynecol Cancer. 2020. PMID: 32973117

7

Olaparib maintenance therapy in patients with newly diagnosed advanced ovarian cancer and a BRCA1 and/or BRCA2 mutation: SOLO1 China cohort.

Wu L, Zhu J, Yin R, Wu X, Lou G, Wang J, Gao Y, Kong B, Lu X, Zhou Q, Wang Y, Chen Y, Lu W, Li W, Cheng Y, Liu J, Ma X, Zhang J. Wu L, et al. Among authors: liu j. Gynecol Oncol. 2021 Jan;160(1):175-181. doi: 10.1016/j.ygyno.2020.10.005. Epub 2020 Nov 27. Gynecol Oncol. 2021. PMID: 33250205 Clinical Trial.

8

An Open-label, Multicenter, Single-arm, Phase II Study of Fluzoparib in Patients with Germline BRCA1/2 Mutation and Platinum-sensitive Recurrent Ovarian Cancer.

Li N, Bu H, Liu J, Zhu J, Zhou Q, Wang L, Yin R, Wu X, Yao S, Gu K, Zhang H, Li G, Pan H, Wu Q, An R, Yang X, Zhu Y, Wan X, Duan W, Xiong J, Guo H, Lou G, Wang J, Hu W, Zhang X, Meng Y, Zhang B, Wang Y, Wang Q, Wu L. Li N, et al. Among authors: liu j. Clin Cancer Res. 2021 May 1;27(9):2452-2458. doi: 10.1158/1078-0432.CCR-20-3546. Epub 2021 Feb 8. Clin Cancer Res. 2021. PMID: 33558426 Clinical Trial.

9

Secondary cytoreduction followed by chemotherapy versus chemotherapy alone in platinum-sensitive relapsed ovarian cancer (SOC-1): a multicentre, open-label, randomised, phase 3 trial.

Shi T, Zhu J, Feng Y, Tu D, Zhang Y, Zhang P, Jia H, Huang X, Cai Y, Yin S, Jiang R, Tian W, Gao W, Liu J, Yang H, Cheng X, Zang R. Shi T, et al. Among authors: liu j. Lancet Oncol. 2021 Apr;22(4):439-449. doi: 10.1016/S1470-2045(21)00006-1. Epub 2021 Mar 8. Lancet Oncol. 2021. PMID: 33705695 Clinical Trial.

10

Elimination of Cervical Cancer: Challenges Promoting the HPV Vaccine in China.

Wei L, Xie X, Liu J, Qiao Y, Zhao F, Wu T, Zhang J, Ma D, Kong B, Chen W, Zhao C, Zhao Y, Li J, Li M, Xia N. Wei L, et al. Among authors: liu j. Indian J Gynecol Oncol. 2021;19(3):51. doi: 10.1007/s40944-021-00536-6. Epub 2021 Jun 27. Indian J Gynecol Oncol. 2021. PMID: 34222614 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

135,765 results

Search Page